<DOC>
	<DOCNO>NCT03046758</DOCNO>
	<brief_summary>The objective trial evaluate safety intraperitoneal administration combination fosfomycin , metronidazole , granulocyte-macrophage colony-stimulating factor ( GM-CSF ) patient undergo surgery uncomplicated appendicitis . Further , sub-trial aim investigate plasma concentration fosfomycin metronidazole intraperitoneal administration .</brief_summary>
	<brief_title>The Safety Pharmacokinetics Intraperitoneal Administration Patients Undergoing Appendectomy Uncomplicated Appendicitis</brief_title>
	<detailed_description />
	<mesh_term>Appendicitis</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<criteria>Men ≥18 year old Suspicion acute appendicitis plan diagnostic laparoscopy eventual appendectomy Written inform consent write verbal information Can understand , read speak Danish Previous allergic reaction fosfomycin , metronidazole , GMCSF Perforated appendicitis ( diagnose either surgery preoperative computer tomography ( CT ) scan ) Diagnostic laparoscopy reveal normal appendix require appendectomy Other intraabdominal pathology require surgical intervention ( diagnose either surgery preoperative CTscan ) Known renal hepatic disease biochemical evidence time admission Known autoimmune disease chronic inflammation Known hematologic disease cancer Previous abdominal surgery ( either laparoscopic open surgery ) Daily use use medication one week prior trial period apart painkiller paracetamol , ibuprofen , tramadol , morphine well drug need anaesthesia , thrombosis prophylaxis , nausea . Limitations antibiotic define Use antimicrobial agent trial treatment one month 24 hour trial treatment Participant another drug trial one month prior date surgery Body mass index ≥35 kg/m2 Weekly intake alcohol &gt; 14 unit , one unit correspond 12 g alcohol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>